{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T19:43:22Z","timestamp":1775159002353,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.vaccine.2003.11.039","type":"journal-article","created":{"date-parts":[[2003,12,12]],"date-time":"2003-12-12T16:09:13Z","timestamp":1071245353000},"page":"2234-2243","source":"Crossref","is-referenced-by-count":106,"title":["Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine"],"prefix":"10.1016","volume":"22","author":[{"given":"Gulnara Patricia","family":"Borja-Cabrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Cruz Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edilma","family":"Paraguai de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian Y","family":"Hashimoto Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Antonio","family":"de A Trivellato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarbas Kiyoshi A","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreia Cerqueira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odair","family":"Genaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopoldina Maria Melo","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisa Beatriz","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.11.039_BIB1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis. Is it time to change strategies","volume":"52","author":"Tesh","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4269\/ajtmh.2001.65.510","article-title":"Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil","volume":"65","author":"Palatnik-de-Sousa","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB4","first-page":"339","article-title":"Le diagnostic pr\u00e9coce de la leishmaniose canine par la ponction ganglionnaire. R\u00e9flexions \u00e0 propos de soixante examens positifs obtenus en dix mois dans la r\u00e9gion Marsellaise","volume":"132","author":"Ranque","year":"1948","journal-title":"Bull. Acad. Nat. Med."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1590\/S0074-02761985000300012","article-title":"Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, parasitological, therapeutical and epidemiological findings (1977\u20131983)","volume":"80","author":"Marzochi","year":"1985","journal-title":"Mem. Inst. Osw. Cruz."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00034989860003","article-title":"Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis","volume":"92","author":"Oliva","year":"1998","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1051\/parasite\/1979543277","article-title":"Ecologie des leishmanioses dans le sud de la France. 10. Les formes \u00e9volutives de la leishmaniose visc\u00e9rale canine. Elaboration d\u2019une typologie bio-clinique \u00e0 finalit\u00e9 \u00e9pid\u00e9miologique","volume":"54","author":"Lanotte","year":"1979","journal-title":"Ann. Parasitol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB8","first-page":"40","article-title":"Zur leishmaniose des hundes. Infektionsverlauf, diagnose un therapieversuche nach exp. Infection vom Beagles mit Leishmania donovani (st. Kalkutta)","volume":"98","author":"Von Reiter","year":"1985","journal-title":"Berl. M\u00fcnc. Tier\u00e4rztl. Wschr."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB9","unstructured":"Organiza\u00e7\u00e3o Mundial da Sa\u00fade. Lucha contra las leishmanioses. Serie de informes t\u00e9cnicos 1990;793:1\u2013177."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2915.1987.tb00364.x","article-title":"Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment","volume":"1","author":"Gradoni","year":"1987","journal-title":"Med. Vet. Entomol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB11","unstructured":"World Health Organization-TDR. The TDR 15th programm report. Research Progress 1999\u20132000. New and Improved Tools; 2003. http:\/\/www.who.int\/tdr\/research\/progress9900\/tools\/vdr.htm."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB12","unstructured":"Modabber, F. Leishmaniasis. In: Tropical disease research progress, 1991\u20131992. Geneva: World Health Organization; 1993. p. 77\u201387."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-3024.1989.tb00676.x","article-title":"Vaccination trial against canine visceral leishmaniasis","volume":"11","author":"Dunan","year":"1989","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0074-02761996000600006","article-title":"Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs","volume":"91","author":"Mayrink","year":"1996","journal-title":"Mem. Inst. Osw. Cruz. MEMIOC"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ije\/15.4.572","article-title":"Controlled field trials of a vaccine against new world cutaneous leishmaniasis","volume":"15","author":"Antunes","year":"1986","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB16","first-page":"166","article-title":"Phase III randomized double blind clinical trial of the efficacy of a vaccine against canine visceral leishmaniasis in urban area of Montes Claros, MG","volume":"91","author":"Genaro","year":"1996","journal-title":"Braz. Mem. Inst. Osw. Cruz. MEMIOC"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB17","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA vaccine and vaccinia recombinant vectors expresssing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A Phase III trial of Efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil(S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB19","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"19\/20","key":"10.1016\/j.vaccine.2003.11.039_BIB20","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0264-410X(03)00046-X","article-title":"IgG1\/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniasis","volume":"21","author":"Mendes","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.57.3.754-763.1989","article-title":"Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate","volume":"57","author":"Palatnik","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0001-706X(93)90006-W","article-title":"Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the fucose\u2013mannose ligand (FML)","volume":"53","author":"Palatnik de Sousa","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB23","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0264-410X(99)00058-4","article-title":"Vaccination with the FML antigen (fucose mannose ligand) of Leishmania donovani in the Swiss Albino model","volume":"17","author":"Santos","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0035-9203(95)90022-5","article-title":"Leishmania donovani: titration of antibodies to the fucose mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis","volume":"89","author":"Palatnik de Sousa","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1999.61.296","article-title":"The FML-ELISA assay in diagnosis and prognosis of canine visceral leishmaniasis","volume":"61","author":"Borja Cabrera","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB27","first-page":"547","article-title":"Experimental murine Leishmania donovani infection: Immunoprotection by the fucose mannose ligand (FML)","volume":"27","author":"Palatnik de Sousa","year":"1994","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB28","first-page":"290","article-title":"The FML vaccine (fucose\u2013mannose ligand) protects hamsters from experimental Kala-Azar","volume":"46","author":"Palatnik de Sousa","year":"1994","journal-title":"Ci\u00eancia e Cultura (J. Braz. Assoc. Adv. Sci.)"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2003.11.039_BIB29","first-page":"175","article-title":"TRALd \u2014A rapid test specific for serodiagnosis of visceral leishmanioses","volume":"21","author":"Badar\u00f3","year":"1997","journal-title":"Acta Parasitol. Tur."},{"issue":"32","key":"10.1016\/j.vaccine.2003.11.039_BIB30","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1016\/S0264-410X(03)00527-9","article-title":"Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine","volume":"21","author":"Santos","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB31","unstructured":"Ranque JM, Quilici M, Dunan S. Les leishmanioses de la region proven\u00e7ale. Considerations epidemiologiques et ecologiques. Colloques Internationaux du CNRS. Ecologie des leishmanioses. Paris: Centre National de la Recherche Scientifique. 1977;239:285\u201393."},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.039_BIB32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2307\/3283159","article-title":"Canine leishmaniasis: pathological and ecological factors influencing trasmission of infection","volume":"77","author":"Abranches","year":"1991","journal-title":"J. Parasitol."},{"issue":"Suppl","key":"10.1016\/j.vaccine.2003.11.039_BIB33","first-page":"154","article-title":"Urban visceral leishmaniasis in Minas Gerais: a picture about the infection in dogs attended in veterinarian clinics in the metropolitan area of Belo Horizonte and Montes Claros, MG","volume":"91","author":"da Costa","year":"1996","journal-title":"Mem. Inst. Osw. Cruz."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB34","unstructured":"Fisher RA, Yates F. Student\u2019s t-test of significance. In: Statistical tables for agricultural, biological and other research workers. Edinburgh: Oliver and Boyd; 1957. p. 157."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/rvsc.2000.0419","article-title":"Canine leishmaniasis transmission: higher infectivity among naturally infected dogs to sandflies is associated with lower proportions of T helper cells","volume":"69","author":"Guarga","year":"2000","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(97)00072-X","article-title":"Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs","volume":"59","author":"Bourdoiseau","year":"1997","journal-title":"Vet. Immunopathol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before and after chemoterapy","volume":"30","author":"Moreno","year":"1999","journal-title":"Vet. Immunopathol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-2427(02)00128-9","article-title":"Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis","volume":"88","author":"Guarga","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB39","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/S0264-410X(00)00118-3","article-title":"Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity","volume":"18","author":"Marciani","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.039_BIB40","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB41","unstructured":"Genaro O, da Costa RT, Fran\u00e7a-Silva JC, Reis AB, Silva JC, Vieira EP, et al. Evaluation of an immunochromatographic assay for the diagnosis of dogs experimentally and naturally infected with Leishmania chagasi in Brazil. Acta Parasitol Tur (Suppl I);1996:93."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"Molano","year":"2003","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/expr.1996.0018","article-title":"Antibody rersponse in dogs experimentally infected with Leishmania infantum: infection course antigen markers","volume":"82","author":"Carrera","year":"1996","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infectes with Leishmania (L.) infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB45","unstructured":"Borja-Cabrera GP. An\u00e1lise do potencial diagn\u00f3stico, progn\u00f3stico e imunoprotetor do ant\u0131\u0301geno FML (ligante de fucose manose) de Leishmania (L.) donovani, no calazar canino experimental e de \u00e1rea end\u00eamica. Ph.D. thesis. Department of Experimental Pathology, Federal Fluminense University; 2000. p:79."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB46","first-page":"121","article-title":"Leishmania and canine leishmanioses","volume":"527","author":"Cardoso","year":"1998","journal-title":"Rev. Port. Cien. Vet."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.vaccine.2003.11.039_BIB49","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1128\/IAI.70.6.2763-2771.2002","article-title":"Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs","volume":"70","author":"Altet","year":"2002","journal-title":"Infect. Immun."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2003.11.039_BIB50","first-page":"201","article-title":"Combined immunotherapy and chemotherapy in canine visceral leishmaniasis. Preliminary findings","volume":"87","author":"Mayrink","year":"1992","journal-title":"Mem. Inst. Osw. Cruz."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T02:00:06Z","timestamp":1585360806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":50,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0264410X03008399"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}